Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tuberous Sclerosis Complex-associated Refractory Seizures × Anticonvulsants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Epilepsy 2 Tuberous Sclerosis Complex-associated Refractory Seizures 1 Tuberous Sclerosis 1 Seizures 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chronic Pain 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Everolimus 1 Anticonvulsants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01713946 2018-11-07

EXIST-3

Novartis

Phase 3 Completed

366 enrolled 38 charts 1 FDA

Tuberous Sclerosis Complex-associated Refractory Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡